Form 4 for BRTX BioRestorative Therapies, Inc.
Accepted 2024-04-10 00:00:00 ET · period of report 2024-04-08 · accession 0001021771-24-000091 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-04-10 | 2024-04-08+ | BRTX | Silva Francisco | VP of Research, Development, Dir | P - Purchase | $1.23 | +8,308 | 155.8K | +6% | +$10.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-08 | P | A | 1,232 | $1.17 | 149,159 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-08 | P | A | 476 | $1.13 | 147,927 | D | — | — | |
| 3 | Common | Common Stock | 2024-04-09 | P | A | 6,600 | $1.25 | 155,759 | D | — | — |